NeuroOne Medical Technologies Corporation Common Stock
NMTC Real Time Price USDRecent trades of NMTC by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by NMTC's directors and management
Government lobbying spending instances
No Corporate Lobbying instances for this ticker
Corporate Lobbying DashboardEstimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
-
Patent Title: Spinal cord stimulation systems, methods, and devices Feb. 13, 2024
-
Patent Title: Minimally invasive electrode and delivery device and related systems and methods Jan. 30, 2024
-
Patent Title: Agent-delivering neural probe devices and related systems and methods Jan. 02, 2024
-
Patent Title: Neural depth probes and related systems and methods Oct. 25, 2022
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of NMTC in WallStreetBets Daily Discussion
Recent insights relating to NMTC
Recent picks made for NMTC stock on CNBC
ETFs with the largest estimated holdings in NMTC
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NMTC Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.